MILFORD, Mass.--(BUSINESS WIRE)--PLC Systems Inc. (OTCBB: PLCSF), a medical device company focused on innovative technologies for the cardiac and vascular markets, today announced that its lead product, RenalGuard®, will be featured during Prevention of Contrast-Induced Kidney Injury: Focus on Hydration & New Frontiers, a 90-minute discussion session at Transcatheter Cardiovascular Therapeutics (TCT) 2012, being held October 22-26, 2012 at the Miami Beach Convention Center.
